首页 > 最新文献

European Journal of Translational Myology最新文献

英文 中文
Serum protein biomarker signature of Duchenne muscular dystrophy. 杜氏肌营养不良症的血清蛋白生物标志物特征。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-27 Epub Date: 2025-05-28 DOI: 10.4081/ejtm.2025.13956
Paul Dowling, Elisa Negroni, Capucine Trollet, Margit Zweyer, Dieter Swandulla, Kay Ohlendieck

In contrast to invasive skeletal muscle biopsies and the associated complexity of tissue sampling techniques and potential detrimental side effects, the alternative application of liquid biopsy procedures has considerable advantages concerning minimal invasiveness, repeated sampling options, assay robustness and cost effectiveness. This article outlines the current status of serum biomarkers used for diagnosing and characterizing Duchenne muscular dystrophy (DMD), a primary muscle wasting disease of early childhood due to primary abnormalities in the extremely large DMD gene. Reviewed are important aspects of the discovery, characterization and diagnostic value of biofluid-based protein markers of dystrophinopathy. This includes an overview of traditional general skeletal muscle damage markers, such as creatine kinase, myoglobin and lactate dehydrogenase, which have been used for many decades in clinical applications to evaluate patients with muscular weakness. In addition, this article outlines the biochemical identification of novel biomarker candidates focusing on the usage of mass spectrometry-based proteomic surveys to establish comprehensive profiles of protein alterations in dystrophinopathy. Pathoproteomic serum markers of myonecrosis with great potential for improved patient screening, differential diagnosis, stage-specific prognosis and therapeutic monitoring include specific isoforms of muscle-derived cytosolic proteins, such as carbonic anhydrase isoform CA3 and fatty acid binding protein FABP3, as well as sarcomeric proteins, including specific isoforms of myosin light chain, myosin binding protein, troponin, and myomesin, in addition to peptide fragments derived from the giant protein titin. Biofluid-associated marker proteins of reactive myofibrosis include the extracellular matrix proteins fibronectin, osteopontin, collagen and matrix-metalloproteinases.

与侵入性骨骼肌活检和相关的组织采样技术的复杂性和潜在的有害副作用相比,液体活检程序的替代应用具有相当大的优势,涉及最小的侵入性,重复采样选项,检测稳健性和成本效益。本文概述了用于诊断和表征杜氏肌营养不良(DMD)的血清生物标志物的现状,杜氏肌营养不良(DMD)是一种早期儿童原发性肌肉萎缩疾病,由于DMD基因的原发性异常。综述了肌营养不良症生物液体蛋白标志物的发现、表征和诊断价值的重要方面。这包括对传统的一般骨骼肌损伤标志物的概述,如肌酸激酶、肌红蛋白和乳酸脱氢酶,这些标志物在临床应用中用于评估肌肉无力患者已有几十年的历史。此外,本文概述了新的生物标志物候选物的生化鉴定,重点是使用基于质谱的蛋白质组学调查来建立营养不良症蛋白质改变的综合概况。肌坏死的病理蛋白质组学血清标记物在改善患者筛查、鉴别诊断、分期特异性预后和治疗监测方面具有巨大潜力,包括肌肉来源的胞质蛋白的特异性同工型,如碳酸酐酶异构体CA3和脂肪酸结合蛋白FABP3,以及肌聚蛋白,包括肌球蛋白轻链、肌球蛋白结合蛋白、肌钙蛋白和肌凝蛋白的特异性同工型。除了肽片段外,还衍生出巨蛋白titin。反应性肌纤维化的生物流体相关标记蛋白包括细胞外基质蛋白纤维连接蛋白、骨桥蛋白、胶原蛋白和基质金属蛋白酶。
{"title":"Serum protein biomarker signature of Duchenne muscular dystrophy.","authors":"Paul Dowling, Elisa Negroni, Capucine Trollet, Margit Zweyer, Dieter Swandulla, Kay Ohlendieck","doi":"10.4081/ejtm.2025.13956","DOIUrl":"10.4081/ejtm.2025.13956","url":null,"abstract":"<p><p>In contrast to invasive skeletal muscle biopsies and the associated complexity of tissue sampling techniques and potential detrimental side effects, the alternative application of liquid biopsy procedures has considerable advantages concerning minimal invasiveness, repeated sampling options, assay robustness and cost effectiveness. This article outlines the current status of serum biomarkers used for diagnosing and characterizing Duchenne muscular dystrophy (DMD), a primary muscle wasting disease of early childhood due to primary abnormalities in the extremely large DMD gene. Reviewed are important aspects of the discovery, characterization and diagnostic value of biofluid-based protein markers of dystrophinopathy. This includes an overview of traditional general skeletal muscle damage markers, such as creatine kinase, myoglobin and lactate dehydrogenase, which have been used for many decades in clinical applications to evaluate patients with muscular weakness. In addition, this article outlines the biochemical identification of novel biomarker candidates focusing on the usage of mass spectrometry-based proteomic surveys to establish comprehensive profiles of protein alterations in dystrophinopathy. Pathoproteomic serum markers of myonecrosis with great potential for improved patient screening, differential diagnosis, stage-specific prognosis and therapeutic monitoring include specific isoforms of muscle-derived cytosolic proteins, such as carbonic anhydrase isoform CA3 and fatty acid binding protein FABP3, as well as sarcomeric proteins, including specific isoforms of myosin light chain, myosin binding protein, troponin, and myomesin, in addition to peptide fragments derived from the giant protein titin. Biofluid-associated marker proteins of reactive myofibrosis include the extracellular matrix proteins fibronectin, osteopontin, collagen and matrix-metalloproteinases.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144175287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of estrogen and progesterone therapy on intraocular pressure: a systematic review and meta-analysis study. 雌激素和孕激素治疗对眼压的影响:一项系统回顾和荟萃分析研究。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-27 Epub Date: 2025-05-08 DOI: 10.4081/ejtm.2025.13497
Behzad Safarpour Lima, Shima Sayanjali, Nir Shoham-Hazon

This systematic review and meta-analysis aimed to assess the effect of Hormone Replacement Therapy (HRT) with estrogen and progesterone on Intraocular Pressure (IOP) in postmenopausal women, with the objective of determining whether HRT can lower IOP and potentially reduce glaucoma risk. Following PRISMA guidelines, a comprehensive search was conducted up to June 2024. Eligible studies included randomized controlled trials and observational studies that reported IOP changes in postmenopausal women undergoing HRT. The pooled mean differences in IOP were calculated using both random-effects and fixed-effect models. The meta-analysis included 9 studies with a total of 1,024 participants. The pooled analysis showed a significant reduction in IOP among women receiving HRT compared to controls, with a mean difference of 3.84 mmHg (95% CI: 2.26 to 5.41, p < 0.01) in the random-effects model, and 2.36 mmHg (95% CI: 2.08 to 2.64, p < 0.01) in the fixed-effect model. Despite these significant results, there was high heterogeneity across studies (I² = 97%), likely due to variations in hormone types, dosages, and treatment durations. HRT is associated with a significant decrease in IOP in postmenopausal women, potentially offering protective benefits against glaucoma, although further research is needed to address the observed variability.

本系统综述和荟萃分析旨在评估雌激素和黄体酮联合激素替代疗法(HRT)对绝经后妇女眼压(IOP)的影响,目的是确定HRT是否可以降低IOP并潜在地降低青光眼的风险。根据PRISMA的指导方针,到2024年6月进行了全面的搜索。符合条件的研究包括随机对照试验和观察性研究,这些研究报告了绝经后妇女接受HRT后IOP的变化。使用随机效应和固定效应模型计算IOP的合并平均差异。荟萃分析包括9项研究,共有1,024名参与者。合并分析显示,与对照组相比,接受HRT的女性IOP显著降低,随机效应模型的平均差异为3.84 mmHg (95% CI: 2.26至5.41,p < 0.01),固定效应模型的平均差异为2.36 mmHg (95% CI: 2.08至2.64,p < 0.01)。尽管有这些显著的结果,但研究之间存在高度异质性(I²= 97%),可能是由于激素类型、剂量和治疗持续时间的差异。HRT与绝经后妇女IOP的显著降低有关,可能对青光眼有保护作用,尽管需要进一步的研究来解决观察到的可变性。
{"title":"Effect of estrogen and progesterone therapy on intraocular pressure: a systematic review and meta-analysis study.","authors":"Behzad Safarpour Lima, Shima Sayanjali, Nir Shoham-Hazon","doi":"10.4081/ejtm.2025.13497","DOIUrl":"10.4081/ejtm.2025.13497","url":null,"abstract":"<p><p>This systematic review and meta-analysis aimed to assess the effect of Hormone Replacement Therapy (HRT) with estrogen and progesterone on Intraocular Pressure (IOP) in postmenopausal women, with the objective of determining whether HRT can lower IOP and potentially reduce glaucoma risk. Following PRISMA guidelines, a comprehensive search was conducted up to June 2024. Eligible studies included randomized controlled trials and observational studies that reported IOP changes in postmenopausal women undergoing HRT. The pooled mean differences in IOP were calculated using both random-effects and fixed-effect models. The meta-analysis included 9 studies with a total of 1,024 participants. The pooled analysis showed a significant reduction in IOP among women receiving HRT compared to controls, with a mean difference of 3.84 mmHg (95% CI: 2.26 to 5.41, p < 0.01) in the random-effects model, and 2.36 mmHg (95% CI: 2.08 to 2.64, p < 0.01) in the fixed-effect model. Despite these significant results, there was high heterogeneity across studies (I² = 97%), likely due to variations in hormone types, dosages, and treatment durations. HRT is associated with a significant decrease in IOP in postmenopausal women, potentially offering protective benefits against glaucoma, although further research is needed to address the observed variability.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144050149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levels of catastrophizing pain and kinesiophobia in patients with osteoarthritis and their association. 骨关节炎患者巨灾性疼痛和运动恐惧症的水平及其相关性。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-27 Epub Date: 2025-05-07 DOI: 10.4081/ejtm.2025.13636
Aristea Vitsa, Ioannis Moisoglou, Petros Galanis, Anastasios Merkouris, Evridiki Papastavrou, Pavlos Sarafis

Aim of the present study was to assess the level of catastrophizing pain and kinesiophobia in patients with osteoarthritis and to investigate the association between catastrophizing pain and kinesiophobia. This follow-up study included 170 osteoarthritis patients undergoing surgery. They completed the Pain Catastrophizing Scale and the Tampa Scale for Kinesiophobia preoperatively (T0) and then postoperatively, at one (T1) and six months (T2). The mean score of catastrophizing pain preoperatively indicates moderate to high level of catastrophic pain. Multivariable linear regression analysis with total score of Pain Catastrophizing Scale preoperatively as the dependent variable found that increased age was associated with increased total score of Pain Catastrophizing Scale. The mean kinesiophobia score preoperatively indicates moderate to high level of kinesiophobia. Multivariable linear regression analysis with total score of the Tampa Scale for Kinesiophobia preoperatively as the dependent variable found that increased age and increased patients' inability to manage pain (helplessness) were associated with increased total score of the Tampa Scale for Kinesiophobia. Increased age and catastrophizing pain are predictors of kinesiophobia. Surgical interventions tend to reduce both catastrophizing pain and kinesiophobia.

本研究的目的是评估骨关节炎患者灾难性疼痛和运动恐惧症的水平,并探讨灾难性疼痛和运动恐惧症之间的关系。这项随访研究包括170名接受手术的骨关节炎患者。术前(T0)和术后(1个月(T1)和6个月(T2)分别完成疼痛灾难量表和运动恐惧症坦帕量表。术前灾难性疼痛的平均评分表明患者有中度至高度的灾难性疼痛。以术前疼痛灾难量表总分为因变量的多变量线性回归分析发现,年龄的增加与疼痛灾难量表总分的增加相关。术前运动恐惧症平均得分表明中度至高度的运动恐惧症。以术前运动恐惧症坦帕量表总分为因变量的多变量线性回归分析发现,患者年龄的增加和疼痛控制能力(无助感)的增加与运动恐惧症坦帕量表总分的增加有关。年龄的增长和灾难性的疼痛是运动恐惧症的预测因素。手术干预倾向于减少灾难性的疼痛和运动恐惧症。
{"title":"Levels of catastrophizing pain and kinesiophobia in patients with osteoarthritis and their association.","authors":"Aristea Vitsa, Ioannis Moisoglou, Petros Galanis, Anastasios Merkouris, Evridiki Papastavrou, Pavlos Sarafis","doi":"10.4081/ejtm.2025.13636","DOIUrl":"10.4081/ejtm.2025.13636","url":null,"abstract":"<p><p>Aim of the present study was to assess the level of catastrophizing pain and kinesiophobia in patients with osteoarthritis and to investigate the association between catastrophizing pain and kinesiophobia. This follow-up study included 170 osteoarthritis patients undergoing surgery. They completed the Pain Catastrophizing Scale and the Tampa Scale for Kinesiophobia preoperatively (T0) and then postoperatively, at one (T1) and six months (T2). The mean score of catastrophizing pain preoperatively indicates moderate to high level of catastrophic pain. Multivariable linear regression analysis with total score of Pain Catastrophizing Scale preoperatively as the dependent variable found that increased age was associated with increased total score of Pain Catastrophizing Scale. The mean kinesiophobia score preoperatively indicates moderate to high level of kinesiophobia. Multivariable linear regression analysis with total score of the Tampa Scale for Kinesiophobia preoperatively as the dependent variable found that increased age and increased patients' inability to manage pain (helplessness) were associated with increased total score of the Tampa Scale for Kinesiophobia. Increased age and catastrophizing pain are predictors of kinesiophobia. Surgical interventions tend to reduce both catastrophizing pain and kinesiophobia.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144052862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longevity concept by regenerative medicine methods synergy: exosome therapy, functional medicine, and advanced multi-wavelengths laser therapy. 长寿概念由再生医学方法协同:外泌体疗法、功能医学和先进的多波长激光疗法。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-27 Epub Date: 2025-05-08 DOI: 10.4081/ejtm.2025.13540
Yasaman Zandi Mehran, Hans Michael Weber, Fateme Hoseinzade, Nahid Tafazoli Harandi, Mozhgan Ayazi, Shila Mirzadeh

Regenerative medicine is one of the most important branches of medicine today and in the future and brings together all the methods to stop or even reverse the aging process. Regenerative medicine may include cellular therapies such as stem cell therapy or extracellular vesicle therapies such as exosomes and growth factor therapy. It may also involve the use of Photobiomodulation (PBM) and functional medicine treatments targets on mitochondrial medicine, to control the aging process. In this article, we have discussed the role, importance, rationale, overlap, and synergy of the joint application of these methods. Combining these regenerative medicine approaches can achieve better results in various medical indications. For longevity, any autoimmune disease, chronic disease, especially in elderly patients, this recommended combination seems to be very critical, for a higher survival rate in cell therapy methods. It is like a plant growing process that requires good quality seeds (cell therapy), light (targeted laser therapy) and good soil (functional medicine).

再生医学是当今和未来最重要的医学分支之一,它汇集了所有阻止甚至逆转衰老过程的方法。再生医学可包括细胞疗法,如干细胞疗法或细胞外囊泡疗法,如外泌体和生长因子疗法。它也可能涉及使用光生物调节(PBM)和功能药物治疗针对线粒体药物,以控制衰老过程。在本文中,我们讨论了这些方法联合应用的作用、重要性、基本原理、重叠和协同作用。结合这些再生医学方法可以在各种医学适应症中取得更好的效果。对于长寿,任何自身免疫性疾病,慢性疾病,特别是老年患者,这种推荐的组合似乎非常关键,因为在细胞治疗方法中存活率更高。这就像一个植物生长的过程,需要优质的种子(细胞治疗),光线(靶向激光治疗)和良好的土壤(功能医学)。
{"title":"Longevity concept by regenerative medicine methods synergy: exosome therapy, functional medicine, and advanced multi-wavelengths laser therapy.","authors":"Yasaman Zandi Mehran, Hans Michael Weber, Fateme Hoseinzade, Nahid Tafazoli Harandi, Mozhgan Ayazi, Shila Mirzadeh","doi":"10.4081/ejtm.2025.13540","DOIUrl":"10.4081/ejtm.2025.13540","url":null,"abstract":"<p><p>Regenerative medicine is one of the most important branches of medicine today and in the future and brings together all the methods to stop or even reverse the aging process. Regenerative medicine may include cellular therapies such as stem cell therapy or extracellular vesicle therapies such as exosomes and growth factor therapy. It may also involve the use of Photobiomodulation (PBM) and functional medicine treatments targets on mitochondrial medicine, to control the aging process. In this article, we have discussed the role, importance, rationale, overlap, and synergy of the joint application of these methods. Combining these regenerative medicine approaches can achieve better results in various medical indications. For longevity, any autoimmune disease, chronic disease, especially in elderly patients, this recommended combination seems to be very critical, for a higher survival rate in cell therapy methods. It is like a plant growing process that requires good quality seeds (cell therapy), light (targeted laser therapy) and good soil (functional medicine).</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144024297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research into the physiology of myosins - a personal odyssey. 肌球蛋白生理学研究——个人的冒险。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-06-27 Epub Date: 2025-03-25 DOI: 10.4081/ejtm.2025.13688
Joseph Foon Yoong Hoh

During my PhD, I worked on the neural regulation of mechanical properties fast and slow muscles. This led me to believe that myosins in fast and slow muscles are structurally distinct and that motor nerves regulate the expression of myosin genes. I devised a method for separating intact fast and slow myosins by gel electrophoresis and confirmed their neural regulation. The electrophoresis method was subsequently improved and used to analyse skeletal and cardiac myosin isoforms in various vertebrate species, including marsupials. This led to the discovery of neonatal myosin heavy chain (MyHC), α and β cardiac MyHCs and of the regulation of cardiac MyHCs by thyroid hormone. Antibodies were raised against 2A, 2X, 2B, masticatory and extraocular MyHCs and used to study the expression and regulation of MyHCs in jaw, laryngeal and Extraocular Muscle (EOM) fibres. Antibodies against masticatory myosin enabled the sequencing of masticatory MyHC and masticatory light chain 2 genes. Cross-bridge kinetics of fibres with different myosin isoforms were analysed. Different MyHC isoforms found in jaw-closing muscles across various species reflected evolutionary adaptations to diverse dietary intake, while MyHC expression changes in cardiac and laryngeal muscles with body mass reflected adaptations to changes in their specific metabolic rate. Transplantation experiments on masticatory and EOMs and cross-innervation experiments between laryngeal and somitic muscles revealed that their capacity to express masticatory or extraocular MyHC were myogenically determined but neural impulse patterns also influence MyHC expression. EOMs are the most complex, expressing 11 MyHC isoforms. Some EOM fibres express faster MyHCs in the endplate zone but slower MyHCs at the end segments, an arrangement helping to linearize the saccade. I suggested that during development, primary and secondary extraocular myotubes specify the synaptic inputs of the innervating neurons to generate impulse patterns which regulate the expression of their MyHCs.

在博士期间,我的研究方向是快肌和慢肌机械性能的神经调节。这让我相信快肌和慢肌中的肌球蛋白在结构上是不同的,运动神经调节着肌球蛋白基因的表达。我设计了一种凝胶电泳分离完整的快肌球蛋白和慢肌球蛋白的方法,并证实了它们的神经调节作用。电泳方法随后得到改进,并用于分析各种脊椎动物(包括有袋动物)的骨骼和心脏肌球蛋白同型异构体。这导致了新生儿肌球蛋白重链(MyHC)、α和β心肌MyHC以及甲状腺激素对心肌MyHC的调节的发现。分别培养针对2A、2X、2B、咀嚼和眼外myhc的抗体,用于研究myhc在颌、喉和眼外肌(EOM)纤维中的表达和调控。抗咀嚼肌球蛋白抗体使咀嚼MyHC和咀嚼轻链2基因测序成为可能。分析了不同肌球蛋白异构体纤维的过桥动力学。在不同物种的下颌肌中发现不同的MyHC亚型,反映了对不同饮食摄入的进化适应,而心肌和喉肌MyHC表达随体重的变化反映了对其特定代谢率变化的适应。咀嚼肌和EOMs的移植实验以及喉肌和躯体肌之间的交叉神经支配实验表明,它们表达咀嚼肌或眼外MyHC的能力是由肌源性决定的,但神经冲动模式也影响MyHC的表达。eom是最复杂的,表达11种MyHC亚型。一些EOM纤维在终板区表达更快的myhc,但在末端段表达更慢的myhc,这种排列有助于将眼跳线性化。我认为,在发育过程中,原发性和继发性眼外肌管指定神经支配神经元的突触输入,以产生调节myhc表达的脉冲模式。
{"title":"Research into the physiology of myosins - a personal odyssey.","authors":"Joseph Foon Yoong Hoh","doi":"10.4081/ejtm.2025.13688","DOIUrl":"10.4081/ejtm.2025.13688","url":null,"abstract":"<p><p>During my PhD, I worked on the neural regulation of mechanical properties fast and slow muscles. This led me to believe that myosins in fast and slow muscles are structurally distinct and that motor nerves regulate the expression of myosin genes. I devised a method for separating intact fast and slow myosins by gel electrophoresis and confirmed their neural regulation. The electrophoresis method was subsequently improved and used to analyse skeletal and cardiac myosin isoforms in various vertebrate species, including marsupials. This led to the discovery of neonatal myosin heavy chain (MyHC), α and β cardiac MyHCs and of the regulation of cardiac MyHCs by thyroid hormone. Antibodies were raised against 2A, 2X, 2B, masticatory and extraocular MyHCs and used to study the expression and regulation of MyHCs in jaw, laryngeal and Extraocular Muscle (EOM) fibres. Antibodies against masticatory myosin enabled the sequencing of masticatory MyHC and masticatory light chain 2 genes. Cross-bridge kinetics of fibres with different myosin isoforms were analysed. Different MyHC isoforms found in jaw-closing muscles across various species reflected evolutionary adaptations to diverse dietary intake, while MyHC expression changes in cardiac and laryngeal muscles with body mass reflected adaptations to changes in their specific metabolic rate. Transplantation experiments on masticatory and EOMs and cross-innervation experiments between laryngeal and somitic muscles revealed that their capacity to express masticatory or extraocular MyHC were myogenically determined but neural impulse patterns also influence MyHC expression. EOMs are the most complex, expressing 11 MyHC isoforms. Some EOM fibres express faster MyHCs in the endplate zone but slower MyHCs at the end segments, an arrangement helping to linearize the saccade. I suggested that during development, primary and secondary extraocular myotubes specify the synaptic inputs of the innervating neurons to generate impulse patterns which regulate the expression of their MyHCs.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":"35 2","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12265422/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of efficacy and safety of generic tacrolimus (Suprotac®) compared to reference tacrolimus (Prograf®) in kidney transplantation: a phase IV study. 非专利他克莫司(Suprotac®)与参比他克莫司(Prograf®)在肾移植中的疗效和安全性评价:一项IV期研究。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 Epub Date: 2025-01-21 DOI: 10.4081/ejtm.2025.13203
Behzad Einollahi, Mohsen Nafar, Mohammad Javanbakht, Amirhesam Alirezaei, Jalal Azmandian, Abbas Etminan, Mohammad Reza Ardalan, Jalal Etemadi, Roghayeh Akbari, Vahid Pourfarziani, Seyed Sadraddin Rasi Hashemi, Seyed Maryam Rahbar, Shahrzad Shahidi, Javid Safa, Hamid Tayyebi Khosroshahi, Sima Abedi Azar, Shahrzad Ossareh, Abdolamir Atapour, Bahareh Marghoob, Fatemeh Nazemian, Hamidreza Kafi, Araz Sabzvari

Transplant recipients are given an immunosuppressive regimen such as tacrolimus to prevent organ rejection. Suprotac® is a generic tacrolimus that is utilized in kidney transplantation regimen in Iran. This post-market study was conducted to evaluate the safety and efficacy of Suprotac® in comparison with Prograf®. In this two-armed, open-label, parallel, active-controlled, and cohort study, de novo kidney transplant recipients aging 18 to 65 years were prescribed Suprotac® or Prograf® as part of the immunosuppressant protocol. The primary outcome was comparing the mean estimated glomerular filtration rate (eGFR) at month 12. The secondary outcomes were the assessment of patient and graft survival, acute rejections during hospitalization, tacrolimus dose, trough concentration, and Trough Concentration/dose (C/D) ratio, and Adverse Events (AEs) during the study period. A total of 201 patients were enrolled in this study. At discharge, the eGFR was lower in the Suprotac® group compared to the Prograf® group (51.70 ml/min/1.73m2 and 57.48 ml/min/1.73m2, respectively; p=0.042). However, at month 12, there was no significant difference in mean eGFR between the two groups (58.94 ml/min/1.73m2 and 59.78 ml/min/1.73m2, respectively; p=0.772). Other outcomes, including patient and graft survival, acute rejection during hospitalization, tacrolimus dose, trough concentration, and C/D ratio, and overall incidence of AEs were similar between the two groups (p >0.05). The efficacy and safety profile of the generic tacrolimus were shown to be comparable to the reference tacrolimus at month 12.

背景:移植受者给予免疫抑制方案,如他克莫司,以防止器官排斥。Suprotac®是一种通用的他克莫司,在伊朗用于肾移植方案。本上市后研究旨在评估Suprotac®与Prograf®的安全性和有效性。方法:在这项双臂、开放标签、平行、主动对照和队列研究中,年龄在18至65岁之间的新肾移植受者被处方Suprotac®或Prograf®作为免疫抑制剂方案的一部分。主要结果是比较12个月时的平均肾小球滤过率(eGFR)。次要结果是评估患者和移植物的生存、住院期间的急性排斥反应、他克莫司剂量、谷浓度、谷浓度/剂量(C/D)比和研究期间的不良事件(ae)。结果:本研究共纳入201例患者。出院时,Suprotac®组eGFR低于Prograf®组(分别为51.70 ml/min/1.73m2和57.48 ml/min/1.73m2);P = 0.042)。然而,在第12个月,两组之间的平均eGFR无显著差异(分别为58.94 ml/min/1.73m2和59.78 ml/min/1.73m2;P = 0.772)。其他结果,包括患者和移植物存活、住院期间急性排斥反应、他克莫司剂量、谷浓度、C/D比和总ae发生率在两组之间相似(p < 0.05)。结论:仿制药他克莫司在12个月时的疗效和安全性与参比药他克莫司相当。
{"title":"Evaluation of efficacy and safety of generic tacrolimus (Suprotac<sup>®</sup>) compared to reference tacrolimus (Prograf<sup>®</sup>) in kidney transplantation: a phase IV study.","authors":"Behzad Einollahi, Mohsen Nafar, Mohammad Javanbakht, Amirhesam Alirezaei, Jalal Azmandian, Abbas Etminan, Mohammad Reza Ardalan, Jalal Etemadi, Roghayeh Akbari, Vahid Pourfarziani, Seyed Sadraddin Rasi Hashemi, Seyed Maryam Rahbar, Shahrzad Shahidi, Javid Safa, Hamid Tayyebi Khosroshahi, Sima Abedi Azar, Shahrzad Ossareh, Abdolamir Atapour, Bahareh Marghoob, Fatemeh Nazemian, Hamidreza Kafi, Araz Sabzvari","doi":"10.4081/ejtm.2025.13203","DOIUrl":"10.4081/ejtm.2025.13203","url":null,"abstract":"<p><p>Transplant recipients are given an immunosuppressive regimen such as tacrolimus to prevent organ rejection. Suprotac® is a generic tacrolimus that is utilized in kidney transplantation regimen in Iran. This post-market study was conducted to evaluate the safety and efficacy of Suprotac® in comparison with Prograf®. In this two-armed, open-label, parallel, active-controlled, and cohort study, de novo kidney transplant recipients aging 18 to 65 years were prescribed Suprotac® or Prograf® as part of the immunosuppressant protocol. The primary outcome was comparing the mean estimated glomerular filtration rate (eGFR) at month 12. The secondary outcomes were the assessment of patient and graft survival, acute rejections during hospitalization, tacrolimus dose, trough concentration, and Trough Concentration/dose (C/D) ratio, and Adverse Events (AEs) during the study period. A total of 201 patients were enrolled in this study. At discharge, the eGFR was lower in the Suprotac® group compared to the Prograf® group (51.70 ml/min/1.73m2 and 57.48 ml/min/1.73m2, respectively; p=0.042). However, at month 12, there was no significant difference in mean eGFR between the two groups (58.94 ml/min/1.73m2 and 59.78 ml/min/1.73m2, respectively; p=0.772). Other outcomes, including patient and graft survival, acute rejection during hospitalization, tacrolimus dose, trough concentration, and C/D ratio, and overall incidence of AEs were similar between the two groups (p >0.05). The efficacy and safety profile of the generic tacrolimus were shown to be comparable to the reference tacrolimus at month 12.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caring skills in nursing students at a university. 大学护理专业学生的关怀技能。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 Epub Date: 2025-03-11 DOI: 10.4081/ejtm.2025.12968
Luz M Caballero-Apaza, Ruben Vidal-Espinoza, Silvia D Curaca-Arroyo, Denices S Abarca-Fernandez, Rossana Gomez-Campos, Marco Cossio-Bolaños

Caring skills are essential in the training of nursing professionals, because they allow them to learn and gain experience in the quality and compassionate care of future patients. The objective is to compare the Caring Skills (CS) in nursing students according to age range, experience and family environment. A descriptive comparative study was carried out. The sample consisted of 176 nursing students from a Peruvian university. The age range was 18 to 27 years. A patient care skills scale was applied. This scale has three indicators (knowledge, courage and patience) and 37 questions. There were no differences in the three indicators (knowledge, courage and patience) when compared by age range (P>0.05). There were significant differences when compared by age range between students living with family and living alone (P<0.05). There was no difference between students who had experience vs. those who had no experience in patient care (P>0.05). It was determined that age and living with family members are determinant in the CS of nursing students of a Peruvian university. There were no differences between experienced and inexperienced students.

护理技能在护理专业人员的培训中是必不可少的,因为它们使他们能够学习和获得对未来病人进行高质量和富有同情心的护理的经验。目的是比较不同年龄、不同经历和不同家庭环境护生的护理技能。进行了描述性比较研究。样本包括来自秘鲁一所大学的176名护理专业学生。年龄在18岁到27岁之间。采用病人护理技能量表。该量表有三个指标(知识、勇气和耐心)和37个问题。在知识、勇气、耐心三项指标上,各年龄组比较差异无统计学意义(P < 0.05)。同住学生与独居学生的年龄差异有统计学意义(P0.05)。在秘鲁一所大学护理专业学生的CS中,年龄和与家庭成员的生活状况是决定因素。有经验的学生和没有经验的学生之间没有差异。
{"title":"Caring skills in nursing students at a university.","authors":"Luz M Caballero-Apaza, Ruben Vidal-Espinoza, Silvia D Curaca-Arroyo, Denices S Abarca-Fernandez, Rossana Gomez-Campos, Marco Cossio-Bolaños","doi":"10.4081/ejtm.2025.12968","DOIUrl":"10.4081/ejtm.2025.12968","url":null,"abstract":"<p><p>Caring skills are essential in the training of nursing professionals, because they allow them to learn and gain experience in the quality and compassionate care of future patients. The objective is to compare the Caring Skills (CS) in nursing students according to age range, experience and family environment. A descriptive comparative study was carried out. The sample consisted of 176 nursing students from a Peruvian university. The age range was 18 to 27 years. A patient care skills scale was applied. This scale has three indicators (knowledge, courage and patience) and 37 questions. There were no differences in the three indicators (knowledge, courage and patience) when compared by age range (P>0.05). There were significant differences when compared by age range between students living with family and living alone (P<0.05). There was no difference between students who had experience vs. those who had no experience in patient care (P>0.05). It was determined that age and living with family members are determinant in the CS of nursing students of a Peruvian university. There were no differences between experienced and inexperienced students.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143606579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Local electrical stimulation: introduction to the problem. 局部电刺激:问题介绍。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 Epub Date: 2025-02-05 DOI: 10.4081/ejtm.2025.13305
Lev G Agasarov, Maxim Yu Yakovlev, Tatyana V Konchugova, Larisa A Marchenkova, Victor A Drobyshev, Tatyana V Apkhanova, Tatyana E Belousova, Tatyana V Marfina, Nadezhda V Gushchina, Valeria A Vasileva, Anastasia A Mukhina, Irina A Grishechkina, Tatyana K Chernyavskaya, Elena P Ivanova

The term "local electrical stimulation" means the delivery, for therapeutic purposes, of electric current signals in the areola of the projections of acupuncture points. Among the varieties of this effect are electro- and electroacupuncture, as well as transcutaneous electrical neurostimulation. In the case of electropuncture, minimal skin areas are irritated, outside of the damage, by placing the sensors according to the projections of the points. In the electroacupuncture, current signals are sent to steel needles immersed in tissues, ensuring the activation of not only skin afferents, but also deeper afferents. Percutaneous stimulation consists of irritating large areas of the skin with the help of portable devices. The paper reveals the mechanisms underlying the therapeutic effect of these methods, and puts forward an assumption about the prevailing biological significance of low-intensity stimuli. In addition, specific examples of use of local electrical stimulation in a number of pathological conditions are also presented.

术语“局部电刺激”是指为治疗目的在穴位投影的乳晕中传递电流信号。这种效果的种类包括电针和电针,以及经皮神经电刺激。在电穿刺的情况下,通过根据点的投影放置传感器,最小的皮肤区域受到刺激,在损伤的外面。在电针中,电流信号被发送到浸入组织中的钢针上,确保不仅激活皮肤传入神经,而且激活更深的传入神经。经皮刺激包括在便携式设备的帮助下刺激大面积的皮肤。本文揭示了这些方法治疗效果的机制,并对低强度刺激的普遍生物学意义提出了假设。此外,在一些病理条件下使用局部电刺激的具体例子也被提出。
{"title":"Local electrical stimulation: introduction to the problem.","authors":"Lev G Agasarov, Maxim Yu Yakovlev, Tatyana V Konchugova, Larisa A Marchenkova, Victor A Drobyshev, Tatyana V Apkhanova, Tatyana E Belousova, Tatyana V Marfina, Nadezhda V Gushchina, Valeria A Vasileva, Anastasia A Mukhina, Irina A Grishechkina, Tatyana K Chernyavskaya, Elena P Ivanova","doi":"10.4081/ejtm.2025.13305","DOIUrl":"10.4081/ejtm.2025.13305","url":null,"abstract":"<p><p>The term \"local electrical stimulation\" means the delivery, for therapeutic purposes, of electric current signals in the areola of the projections of acupuncture points. Among the varieties of this effect are electro- and electroacupuncture, as well as transcutaneous electrical neurostimulation. In the case of electropuncture, minimal skin areas are irritated, outside of the damage, by placing the sensors according to the projections of the points. In the electroacupuncture, current signals are sent to steel needles immersed in tissues, ensuring the activation of not only skin afferents, but also deeper afferents. Percutaneous stimulation consists of irritating large areas of the skin with the help of portable devices. The paper reveals the mechanisms underlying the therapeutic effect of these methods, and puts forward an assumption about the prevailing biological significance of low-intensity stimuli. In addition, specific examples of use of local electrical stimulation in a number of pathological conditions are also presented.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Padua Days on Muscle and Mobility Medicine, March 25-29, 2025, Hotel Petrarca, Euganean Thermae, Italy: Program and Abstracts. 帕多瓦日肌肉和运动医学,2025年3月25日至29日,佩特拉卡酒店,欧洲温泉,意大利:程序和摘要。
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 Epub Date: 2025-03-05 DOI: 10.4081/ejtm.2025.13789
Barbara Ravara, Paolo Gargiulo, David Hood, Lars Larsson, Christiaan Leeuwenburgh, Maria Chiara Maccarone, Stefano Masiero, Philippe Perrin, Amber Pond, Riccardo Rosati, Piera Smeriglio, Lee Sweeney, Daniela Tavian, Gerd Fabian Volk, Ugo Carraro

Medium-sized scientific conferences held in hotels large enough to accommodate all participants increase opportunities for constructive discussion during breaks, and for evenings that bring together young and senior experts of basic sciences and clinical specialties. Time for group discussions offer opportunities for new collaborations and for jobs for young researchers. Since 1991 the Padova Muscle Days have offered collaborative opportunities that have matured into innovative multidisciplinary results to the point that it came naturally for us to underline it with a neologism now included in the title of the 2025 event: "Mobility Medicine". It is a discipline which developed naturally when we brought together fragmented areas of knowledge into one meeting. The Padua Days on Muscle and Mobility Medicine 2025 (2025Pdm3) will be hosted at the Hotel Petrarca, Euganean Thermae (Padua, Italy) from 25 to 29 March 2025. The list of unique sessions within the included program and the following Collection of Abstracts testify that it is possible to organize valid countermeasures to the inevitable tendencies towards hyper-specialization that the explosive increase in scientific progress brings. The European Journal of Translational Myology and Mobility Medicine (Ejtm3) will accept typescripts on results presented at the 2025Pdm3. Furthermore, an additional option for publication of full original Articles or Reviews is the Special "New Trends in Musculoskeletal Imaging" of the MDPI Journal Diagnostics, because diagnosis is essential to manage and follow-up neuro- metabolic- muscular- disorder and the decay of performances in aging. We hope that many will share our dreams and we make them come true at the 2025 Pdm3 Conference.

在大到足以容纳所有参与者的酒店举行的中型科学会议增加了在休息时间进行建设性讨论的机会,并在晚上将基础科学和临床专业的年轻和资深专家聚集在一起。小组讨论的时间为年轻的研究人员提供了新的合作和工作机会。自1991年以来,帕多瓦肌肉日提供了合作机会,已经成熟为创新的多学科成果,以至于我们自然而然地用一个新词来强调它,现在包括在2025年活动的标题中:“运动医学”。当我们把支离破碎的知识领域汇集到一个会议上时,这是一门自然发展起来的学科。2025年帕多瓦肌肉和运动医学日(2025Pdm3)将于2025年3月25日至29日在意大利帕多瓦的Euganean Thermae佩特拉卡酒店举办。所包括的计划中的独特会议列表和以下摘要集证明,有可能组织有效的对策,以应对科学进步的爆炸性增长所带来的不可避免的高度专业化趋势。欧洲翻译骨髓学和运动医学杂志(Ejtm3)将接受2025Pdm3上提交的结果的打字稿。此外,发表完整原创文章或评论的另一个选择是MDPI杂志诊断的特别“肌肉骨骼成像的新趋势”,因为诊断对于管理和随访神经代谢肌肉疾病和衰老过程中的性能衰退至关重要。我们希望更多的人分享我们的梦想,我们将在2025年Pdm3大会上实现这些梦想。
{"title":"Padua Days on Muscle and Mobility Medicine, March 25-29, 2025, Hotel Petrarca, Euganean Thermae, Italy: Program and Abstracts.","authors":"Barbara Ravara, Paolo Gargiulo, David Hood, Lars Larsson, Christiaan Leeuwenburgh, Maria Chiara Maccarone, Stefano Masiero, Philippe Perrin, Amber Pond, Riccardo Rosati, Piera Smeriglio, Lee Sweeney, Daniela Tavian, Gerd Fabian Volk, Ugo Carraro","doi":"10.4081/ejtm.2025.13789","DOIUrl":"10.4081/ejtm.2025.13789","url":null,"abstract":"<p><p>Medium-sized scientific conferences held in hotels large enough to accommodate all participants increase opportunities for constructive discussion during breaks, and for evenings that bring together young and senior experts of basic sciences and clinical specialties. Time for group discussions offer opportunities for new collaborations and for jobs for young researchers. Since 1991 the Padova Muscle Days have offered collaborative opportunities that have matured into innovative multidisciplinary results to the point that it came naturally for us to underline it with a neologism now included in the title of the 2025 event: \"Mobility Medicine\". It is a discipline which developed naturally when we brought together fragmented areas of knowledge into one meeting. The Padua Days on Muscle and Mobility Medicine 2025 (2025Pdm3) will be hosted at the Hotel Petrarca, Euganean Thermae (Padua, Italy) from 25 to 29 March 2025. The list of unique sessions within the included program and the following Collection of Abstracts testify that it is possible to organize valid countermeasures to the inevitable tendencies towards hyper-specialization that the explosive increase in scientific progress brings. The European Journal of Translational Myology and Mobility Medicine (Ejtm3) will accept typescripts on results presented at the 2025Pdm3. Furthermore, an additional option for publication of full original Articles or Reviews is the Special \"New Trends in Musculoskeletal Imaging\" of the MDPI Journal Diagnostics, because diagnosis is essential to manage and follow-up neuro- metabolic- muscular- disorder and the decay of performances in aging. We hope that many will share our dreams and we make them come true at the 2025 Pdm3 Conference.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative analysis of Rotterdam score and neutrophil-to-lymphocyte ratio in predicting outcomes for patients with moderate to severe traumatic brain injury. 鹿特丹评分和中性粒细胞与淋巴细胞比值预测中重度创伤性脑损伤患者预后的比较分析
IF 1.8 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-03-31 Epub Date: 2025-02-21 DOI: 10.4081/ejtm.2025.13443
Hamidreza Aghadoost, Ghazaleh Salehabadi, Esmaeil Fakharian, Hanieh Jafari Mohammadabad

This study aimed to evaluate the role of NLR in predicting outcomes for patients with moderate to severe TBI. A retrospective analysis was conducted from April 2020 to April 2022, including patients aged 16 and older with Glasgow Coma Scale (GCS) scores of 8 or below admitted to Shahid Beheshti Hospital, Kashan. Data on NLR and other clinical markers were collected. Rotterdam scores were calculated using CT scan findings. Patients were followed up for six months post-trauma or until death, and associations between NLR and clinical outcomes were analyzed, with significance set at P < 0.05. Among 195 patients, 130 (66%) had unfavorable outcomes at six months. Admission NLR was significantly higher in patients with unfavorable outcomes compared to those with favorable outcomes (P < 0.001). Receiver operating characteristic analysis indicated that NLR had a sensitivity of 82% and specificity of 91% at a threshold of 5.2 for predicting unfavorable outcomes. Elevated admission NLR in patients with severe TBI was linked to unfavorable six-month functional outcomes and mortality. NLR may serve as a readily accessible clinical marker for prognostication in moderate to severe TBI.

本研究旨在评估NLR在预测中重度TBI患者预后中的作用。回顾性分析了2020年4月至2022年4月期间在卡尚Shahid Beheshti医院住院的16岁及以上格拉斯哥昏迷量表(GCS)评分为8分或以下的患者。收集NLR及其他临床指标数据。鹿特丹评分采用CT扫描结果计算。患者在创伤后随访6个月或至死亡,分析NLR与临床结果的相关性,P < 0.05为显著性。在195例患者中,130例(66%)在6个月时出现不良结果。预后不良的患者入院NLR明显高于预后良好的患者(P < 0.001)。受试者工作特征分析表明,NLR预测不良预后的敏感性为82%,特异性为91%,阈值为5.2。严重TBI患者入院NLR升高与不利的6个月功能结局和死亡率有关。NLR可作为中重度脑外伤患者预后的临床指标。
{"title":"A comparative analysis of Rotterdam score and neutrophil-to-lymphocyte ratio in predicting outcomes for patients with moderate to severe traumatic brain injury.","authors":"Hamidreza Aghadoost, Ghazaleh Salehabadi, Esmaeil Fakharian, Hanieh Jafari Mohammadabad","doi":"10.4081/ejtm.2025.13443","DOIUrl":"10.4081/ejtm.2025.13443","url":null,"abstract":"<p><p>This study aimed to evaluate the role of NLR in predicting outcomes for patients with moderate to severe TBI. A retrospective analysis was conducted from April 2020 to April 2022, including patients aged 16 and older with Glasgow Coma Scale (GCS) scores of 8 or below admitted to Shahid Beheshti Hospital, Kashan. Data on NLR and other clinical markers were collected. Rotterdam scores were calculated using CT scan findings. Patients were followed up for six months post-trauma or until death, and associations between NLR and clinical outcomes were analyzed, with significance set at P < 0.05. Among 195 patients, 130 (66%) had unfavorable outcomes at six months. Admission NLR was significantly higher in patients with unfavorable outcomes compared to those with favorable outcomes (P < 0.001). Receiver operating characteristic analysis indicated that NLR had a sensitivity of 82% and specificity of 91% at a threshold of 5.2 for predicting unfavorable outcomes. Elevated admission NLR in patients with severe TBI was linked to unfavorable six-month functional outcomes and mortality. NLR may serve as a readily accessible clinical marker for prognostication in moderate to severe TBI.</p>","PeriodicalId":46459,"journal":{"name":"European Journal of Translational Myology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143484285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Translational Myology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1